File Download
 
 
Supplementary

Conference Paper: Polypoidal Choroidal Vasculopathy - all you need to know!
  • Basic View
  • Metadata View
  • XML View
TitlePolypoidal Choroidal Vasculopathy - all you need to know!
 
AuthorsWong, I
Lai, W
Wong, D
 
Issue Date2012
 
PublisherWOC2012.
 
CitationThe World Ophthalmology Congress 2012 (WOC2012), Abu Dhabi, United Arab Emirates, 16-20 February 2012. In Scientific Program of WOC2012, 2012, p. 116 [How to Cite?]
 
AbstractOBJECTIVES: To highlight the clinical features, diagnostic criteria, treatment strategies, and future developments in polypoidal choroidal vasculopathy (PCV). SUMMARY OF CONTENT: PCV is characterized by recurrent subretinal pigment epithelial hemorrhages. Before indocyanine-green angiography (ICG) imaging was popular, PCV was sometimes misdiagnosed as neovascular age-related macular degeneration (AMD). With the advent of imaging modalities and deeper understandings of the disease, PCV is now recognized as a separate entity, with its own unique profile of clinical manifestations. Treatment strategy towards PCV has been revolutionized by recent clinical trials using combination therapy with ranibizumab and verteporfin. Currently, significant differences exist between treatment for PCV and neovascular AMD. There is a clear need in distinguishing PCV from neovascular AMD. Clinical photos, ICG findings, and optical coherence tomography scans will be used to illustrate real cases. Small quiz towards end of course will help audience fortify knowledge acquired. At the conclusion of this course, the audience will be able to distinguish a case of PCV, from a case of neovascular AMD. They will know how to formulate treatment strategies for a new case of PCV, and the most up-to-date evidences involved.
 
DescriptionCO-RET-MO 415
 
DC FieldValue
dc.contributor.authorWong, I
 
dc.contributor.authorLai, W
 
dc.contributor.authorWong, D
 
dc.date.accessioned2012-09-20T08:50:22Z
 
dc.date.available2012-09-20T08:50:22Z
 
dc.date.issued2012
 
dc.description.abstractOBJECTIVES: To highlight the clinical features, diagnostic criteria, treatment strategies, and future developments in polypoidal choroidal vasculopathy (PCV). SUMMARY OF CONTENT: PCV is characterized by recurrent subretinal pigment epithelial hemorrhages. Before indocyanine-green angiography (ICG) imaging was popular, PCV was sometimes misdiagnosed as neovascular age-related macular degeneration (AMD). With the advent of imaging modalities and deeper understandings of the disease, PCV is now recognized as a separate entity, with its own unique profile of clinical manifestations. Treatment strategy towards PCV has been revolutionized by recent clinical trials using combination therapy with ranibizumab and verteporfin. Currently, significant differences exist between treatment for PCV and neovascular AMD. There is a clear need in distinguishing PCV from neovascular AMD. Clinical photos, ICG findings, and optical coherence tomography scans will be used to illustrate real cases. Small quiz towards end of course will help audience fortify knowledge acquired. At the conclusion of this course, the audience will be able to distinguish a case of PCV, from a case of neovascular AMD. They will know how to formulate treatment strategies for a new case of PCV, and the most up-to-date evidences involved.
 
dc.description.naturelink_to_OA_fulltext
 
dc.descriptionCO-RET-MO 415
 
dc.description.otherThe World Ophthalmology Congress 2012 (WOC2012), Abu Dhabi, United Arab Emirates, 16-20 February 2012. In Scientific Program of WOC2012, 2012, p. 116
 
dc.identifier.citationThe World Ophthalmology Congress 2012 (WOC2012), Abu Dhabi, United Arab Emirates, 16-20 February 2012. In Scientific Program of WOC2012, 2012, p. 116 [How to Cite?]
 
dc.identifier.epage116
 
dc.identifier.hkuros207468
 
dc.identifier.spage116
 
dc.identifier.urihttp://hdl.handle.net/10722/166819
 
dc.languageeng
 
dc.publisherWOC2012.
 
dc.publisher.placeUnited Arab Emirates
 
dc.relation.ispartofScientific Program of WOC2012
 
dc.titlePolypoidal Choroidal Vasculopathy - all you need to know!
 
dc.typeConference_Paper
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Wong, I</contributor.author>
<contributor.author>Lai, W</contributor.author>
<contributor.author>Wong, D</contributor.author>
<date.accessioned>2012-09-20T08:50:22Z</date.accessioned>
<date.available>2012-09-20T08:50:22Z</date.available>
<date.issued>2012</date.issued>
<identifier.citation>The World Ophthalmology Congress 2012 (WOC2012), Abu Dhabi, United Arab Emirates, 16-20 February 2012. In Scientific Program of WOC2012, 2012, p. 116</identifier.citation>
<identifier.uri>http://hdl.handle.net/10722/166819</identifier.uri>
<description>CO-RET-MO 415</description>
<description.abstract>OBJECTIVES: To highlight the clinical features, diagnostic criteria, treatment strategies, and future developments in polypoidal choroidal vasculopathy (PCV). SUMMARY OF CONTENT: PCV is characterized by recurrent subretinal pigment epithelial hemorrhages. Before indocyanine-green angiography (ICG) imaging was popular, PCV was sometimes misdiagnosed as neovascular age-related macular degeneration (AMD). With the advent of imaging modalities and deeper understandings of the disease, PCV is now recognized as a separate entity, with its own unique profile of clinical manifestations. Treatment strategy towards PCV has been revolutionized by recent clinical trials using combination therapy with ranibizumab and verteporfin. Currently, significant differences exist between treatment for PCV and neovascular AMD. There is a clear need in distinguishing PCV from neovascular AMD. Clinical photos, ICG findings, and optical coherence tomography scans will be used to illustrate real cases. Small quiz towards end of course will help audience fortify knowledge acquired. At the conclusion of this course, the audience will be able to distinguish a case of PCV, from a case of neovascular AMD. They will know how to formulate treatment strategies for a new case of PCV, and the most up-to-date evidences involved.</description.abstract>
<language>eng</language>
<publisher>WOC2012.</publisher>
<relation.ispartof>Scientific Program of WOC2012</relation.ispartof>
<title>Polypoidal Choroidal Vasculopathy - all you need to know!</title>
<type>Conference_Paper</type>
<description.nature>link_to_OA_fulltext</description.nature>
<identifier.hkuros>207468</identifier.hkuros>
<identifier.spage>116</identifier.spage>
<identifier.epage>116</identifier.epage>
<publisher.place>United Arab Emirates</publisher.place>
<description.other>The World Ophthalmology Congress 2012 (WOC2012), Abu Dhabi, United Arab Emirates, 16-20 February 2012. In Scientific Program of WOC2012, 2012, p. 116</description.other>
<bitstream.url>http://hub.hku.hk/bitstream/10722/166819/1/re01.htm</bitstream.url>
</item>